Milk fat globule membrane ameliorates depressive-like behaviors in chronic unpredictable mild stress rats by

Li Huang1, Yunqin Zheng1, Qianfeng Liu1

  • 1Department of Nutrition and Food Science, School of Public Health, Tianjin Medical University, 22 Qixiangtai Road, Heping District, Tianjin 300070, China.

Insights

Milk fat globule membrane (MFGM) alleviates depression-like behaviors in rats by modulating the gut microbiota and increasing beneficial metabolites. This suggests MFGM

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Psychiatry

Background:

  • The gut-brain axis plays a crucial role in depression pathogenesis.
  • Microbiota imbalances are linked to psychiatric disorders.
  • Milk fat globule membrane (MFGM) influences gut health and brain function.

Purpose of the Study:

  • To investigate MFGM's efficacy in ameliorating depression-like behaviors induced by chronic unpredictable mild stress (CUMS).
  • To elucidate the underlying mechanisms involving gut microbiota modulation and metabolite production.

Main Methods:

  • Rats subjected to CUMS were fed an MFGM diet for 5 weeks.
  • Assessment of depressive behaviors, neurotransmitters, hormones, gut microbiota, short-chain fatty acids (SCFAs), and tight junction proteins (occludin, ZO-1).
  • Fecal microbiota transplantation (FMT) experiment to confirm microbial transfer effects.

Main Results:

  • MFGM significantly alleviated depressive-like behaviors in CUMS rats.
  • MFGM improved intestinal barrier integrity by up-regulating occludin and ZO-1 expression.
  • MFGM modulated neurotransmitter levels (increased 5-HT, DA, norepinephrine) and decreased stress hormones.
  • MFGM treatment led to increased SCFAs and monoamine neurotransmitters in recipient rats via FMT.

Conclusions:

  • MFGM demonstrates antidepressant-like effects in a rat model of depression.
  • MFGM's benefits are associated with positive modulation of the gut microbiota, enhanced SCFA production, and normalized neurotransmitter levels.
  • MFGM represents a potential therapeutic or preventative strategy for depression by targeting the microbiota-gut-brain axis.

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...